CenteneCNC
Market Cap: $37.3B
About: Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.
Employees: 67,700
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
36% more call options, than puts
Call options by funds: $198M | Put options by funds: $146M
2.99% more ownership
Funds ownership: 94.7% [Q1] → 97.69% (+2.99%) [Q2]
9% less repeat investments, than reductions
Existing positions increased: 321 | Existing positions reduced: 353
4% less funds holding
Funds holding: 911 [Q1] → 877 (-34) [Q2]
11% less funds holding in top 10
Funds holding in top 10: 9 [Q1] → 8 (-1) [Q2]
13% less capital invested
Capital invested by funds: $39.7B [Q1] → $34.6B (-$5.13B) [Q2]
28% less first-time investments, than exits
New positions opened: 87 | Existing positions closed: 121
Research analyst outlook
18 Wall Street Analysts provided 1 year price targets over the past 3 months
18 analyst ratings
Cantor Fitzgerald Sarah James 66% 1-year accuracy 82 / 125 met price target | 27%upside $90 | Overweight Reiterated | 10 Sept 2024 |
Barclays Andrew Mok 77% 1-year accuracy 34 / 44 met price target | 37%upside $97 | Overweight Maintained | 5 Sept 2024 |
Barclays Andrew Mok 77% 1-year accuracy 34 / 44 met price target | 38%upside $98 | Overweight Maintained | 22 Aug 2024 |
Cantor Fitzgerald Sarah James 66% 1-year accuracy 82 / 125 met price target | 27%upside $90 | Overweight Reiterated | 19 Aug 2024 |
Stephens & Co. Scott Fidel 87% 1-year accuracy 27 / 31 met price target | 10%upside $78 | Equal-Weight Reiterated | 5 Aug 2024 |
Financial journalist opinion
Based on 17 articles about CNC published over the past 30 days